Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 15920030)

Published in Arterioscler Thromb Vasc Biol on May 26, 2005

Authors

Kurt Reifenberg1, Hans-Anton Lehr, Daniela Baskal, Elena Wiese, Stephan C Schaefer, Steven Black, David Samols, Michael Torzewski, Karl J Lackner, Matthias Husmann, Maria Blettner, Sucharit Bhakdi

Author Affiliations

1: Central Laboratory Animal Facility, Johannes Gutenberg University Mainz, Germany.

Articles citing this

Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation (2009) 2.83

Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension (2011) 1.71

Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov (2011) 1.48

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol (2005) 1.37

Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A (2007) 1.37

The connection between C-reactive protein and atherosclerosis. Ann Med (2008) 1.29

C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells. J Immunol (2008) 1.21

The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta (2012) 1.20

Pattern recognition by pentraxins. Adv Exp Med Biol (2009) 1.19

No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. J Biol Chem (2010) 1.11

CRP--marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol (2005) 1.02

Vitamin C treatment reduces elevated C-reactive protein. Free Radic Biol Med (2008) 1.01

Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. J Immunol (2006) 1.01

Role of leptin in atherogenesis. Exp Clin Cardiol (2006) 0.94

Atherosclerosis-related functions of C-reactive protein. Cardiovasc Hematol Disord Drug Targets (2010) 0.87

Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis. J Biol Chem (2011) 0.86

C-reactive protein and atherogenesis: new insights from established animal models. Am J Pathol (2005) 0.86

Recognition functions of pentameric C-reactive protein in cardiovascular disease. Mediators Inflamm (2014) 0.86

Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain. Am J Pathol (2007) 0.86

Recurrent mutations at C-reactive protein gene promoter SNP position -286 in human cancers. Cell Res (2014) 0.84

Neointimal formation is reduced after arterial injury in human crp transgenic mice. Atherosclerosis (2008) 0.83

Animal models of C-reactive protein. Mediators Inflamm (2014) 0.77

Functional transformation of C-reactive protein by hydrogen peroxide. J Biol Chem (2017) 0.75

Articles by these authors

Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2011) 6.94

Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med (2009) 6.62

The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res (2008) 5.69

Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol (2005) 5.53

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med (2009) 4.94

Generating survival times to simulate Cox proportional hazards models. Stat Med (2005) 4.87

Childhood leukemia in the vicinity of nuclear power plants in Germany. Dtsch Arztebl Int (2008) 4.60

C-reactive Protein. J Biol Chem (2004) 4.39

Confidence interval or p-value?: part 4 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 3.86

Leukaemia in young children living in the vicinity of German nuclear power plants. Int J Cancer (2008) 2.94

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med (2002) 2.90

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med (2003) 2.87

Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation (2010) 2.84

Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation (2009) 2.83

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis (2006) 2.82

Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol (2006) 2.74

Prevalence of wine intolerance: results of a survey from Mainz, Germany. Dtsch Arztebl Int (2012) 2.67

Iatrogenic acute aortic dissection type A: insight from the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg (2013) 2.55

Pneumococcal vaccination in developing countries. Lancet (2006) 2.45

Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol (2006) 2.38

Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer (2003) 2.37

Judging a plethora of p-values: how to contend with the problem of multiple testing--part 10 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2010) 2.36

Vaccines for the twenty-first century society. Nat Rev Immunol (2011) 2.34

The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30

Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol (2008) 2.29

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res (2005) 2.24

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A (2002) 2.20

What does minor elevation of C-reactive protein signify? Am J Med (2006) 2.14

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J (2006) 2.10

Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10

CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost (2004) 2.09

Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05

Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies. J Clin Epidemiol (2002) 1.99

FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res (2005) 1.97

Are pre- or postnatal diagnostic X-rays a risk factor for childhood cancer? A systematic review. Radiat Environ Biophys (2008) 1.93

Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients. Int J Colorectal Dis (2011) 1.91

A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res (2012) 1.83

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J (2008) 1.82

C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res (2007) 1.82

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol (2010) 1.82

Types of study in medical research: part 3 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.80

Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J (2010) 1.80

On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2012) 1.78

Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res (2006) 1.76

Descriptive statistics: the specification of statistical measures and their presentation in tables and graphs. Part 7 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.76

Knowledge about infection with human papillomavirus: a systematic review. Prev Med (2007) 1.75

Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol (2010) 1.75

The performance of methods for correcting measurement error in case-control studies. Epidemiology (2002) 1.71

Critical appraisal of scientific articles: part 1 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.68

Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol (2004) 1.68

Case-control study on childhood cancer in the vicinity of nuclear power plants in Germany 1980-2003. Eur J Cancer (2007) 1.64

A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63

Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS One (2012) 1.61

Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med (2014) 1.61

Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J (2004) 1.58

Radiation protection in diagnostic radiology. Dtsch Arztebl Int (2008) 1.56

Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer (2005) 1.54

Survival analysis: part 15 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2011) 1.54

Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology (2003) 1.53

Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging (2011) 1.52

Global functional analyses of cellular responses to pore-forming toxins. PLoS Pathog (2011) 1.52

Vaccine discovery and translation of new vaccine technology. Lancet (2011) 1.51

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine (2009) 1.50

Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.50

Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet (2013) 1.49

Validation of self-reported cellular phone use. J Expo Anal Environ Epidemiol (2004) 1.48

Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol (2012) 1.47

EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric and young adult CT. J Radiol Prot (2015) 1.46

Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem (2004) 1.46

Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004. Int J Cancer (2008) 1.45

Linear regression analysis: part 14 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2010) 1.44

Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis. FEBS Lett (2008) 1.44

Automated flow cytometric analysis of blood cells in cerebrospinal fluid: analytic performance. Am J Clin Pathol (2004) 1.41

The human face of simulation: patient-focused simulation training. Acad Med (2006) 1.41

Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet (2011) 1.40

Biocompatibility of alginates for grafting: impact of alginate molecular weight. Artif Cells Blood Substit Immobil Biotechnol (2003) 1.40

Cerebral protection during surgery for acute aortic dissection type A: results of the German Registry for Acute Aortic Dissection Type A (GERAADA). Circulation (2011) 1.40

Intraoperative neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg (2013) 1.39

Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company. Dtsch Arztebl Int (2015) 1.39

Effectiveness of the pneumococcal conjugate vaccine for pneumonia in children. Pediatr Infect Dis J (2011) 1.39

Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology (2005) 1.35

Differential role of p38 mitogen activated protein kinase for cellular recovery from attack by pore-forming S. aureus alpha-toxin or streptolysin O. Biochem Biophys Res Commun (2006) 1.34

Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology (2003) 1.33

Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol (2003) 1.32

Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2010) 1.32

Loss of tumor suppressor protein PTEN during renal carcinogenesis. Int J Cancer (2002) 1.31

Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J Biol Chem (2006) 1.31

Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet (2012) 1.29

Study design in medical research: part 2 of a series on the evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.29

Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events. FASEB J (2001) 1.28

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res (2008) 1.28

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol (2009) 1.26